Skip to content

Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.

Randomized controlled trial · J Alzheimers Dis · 2016. Source record refreshed; an explanation has not been reviewed.

Randomized controlled trialSource: PubMed · PMID 26967222

About this paper

This page identifies the publication and its source. A checked explanation of its findings is not yet available.

Reading this record

Checking bibliographic metadata does not verify a study’s conclusions or any advice previously linked to it.

CHECK THE ORIGINAL

Publication details

Efficacy and Safety of Sustained Release Donepezil High Dose versus Immediate Release Donepezil Standard Dose in Japanese Patients with Severe Alzheimer's Disease: A Randomized, Double-Blind Trial.

Homma A, Atarashi H, Kubota N et al.
J Alzheimers Dis · 2016

PubMed ID
26967222
Record checked

A checked publication record confirms source details. It does not verify a health claim or assess the quality of the study. Our approach.